Varex Imaging Corporation
Varex Imaging Corporation (VREX) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
vrex · pe ratio · data through Oct 3, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Varex Imaging Corporation (VREX) measures how much investors pay for each dollar of the company's trailing earnings. VREX's current PE ratio of N/A is calculated by dividing its stock price of $10.35 by its TTM earnings per share of -$1.97.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-10-03
PE Ratio History
2013 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 10 fiscal years · Front-end computedMinQ1 · 25%20.3x
MedianQ3 · 75%70.3x
Max
At N/A, VREX's current P/E is lower than in 0% of its annual fiscal year readings over the past 10 years — historically low.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Medical - Devices · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Varex Imaging CorporationYou VREX | $436M | N/A | — | -$1.97 |
 Avanos Medical, Inc. AVNS | $1.2B | N/A | — | -$1.46 |
 Bicycle Therapeutics plc BCYC | $285M | N/A | — | -$3.16 |
 CeriBell, Inc. CBLL | $694M | N/A | — | -$1.46 |
 Cullinan Therapeutics, Inc. CGEM | $811M | N/A | — | -$3.72 |
 Cytek Biosciences, Inc. CTKB | $520M | N/A | — | -$0.52 |
 Standard BioTools Inc. LAB | $319M | N/A | — | -$0.20 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-10-03Latest FY2025 | — | $-1.70 | — | |
2024-09-27 FY2024 | — | $-1.17 | — | |
2023-09-29 FY2023 | 15.98x | $1.18 | -42.5% | |
2022-09-30 FY2022 | 27.77x | $0.76 | -57.0% | |
2021-10-01 FY2021 | 64.55x | $0.44 | — | |
2020-10-02 FY2020 | — | $-1.49 | — | |
2019-09-30 FY2019 | 70.34x | $0.41 | +82.9% | |
2018-09-30 FY2018 | 38.47x | $0.73 | +56.0% | |
2017-09-30 FY2017 | 24.66x | $1.37 | +57.1% | |
2016-09-30 FY2016 | 15.70x | $1.79 | +16.8% |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Varex Imaging Corporation (VREX) measures how much investors pay for each dollar of the company's trailing earnings. VREX's current PE ratio of N/A is calculated by dividing its stock price of $10.35 by its TTM earnings per share of -$1.97.
Frequently asked questions
VREX pe ratio · 6 questionsVREX's current PE ratio is N/A as of 2026-06-08, based on a stock price of $10.35 and TTM EPS of -$1.97. Data sourced from Financial Modeling Prep via VREX's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Varex Imaging Corporation SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08